# Parth Khanna
Najpopularniejsze odcinki podcastów
Zaktualizowano:
Top podcast episodes featuring parth khanna.
Tim Cole, Founder and CEO at The Compass Alliance: The New Model for Crisis Leadership in Life Sciences
The Launchpad Podcast highlights change agents working to disrupt life sciences and their strategies for success in the ever-changing post-market promotion landscape.
In our third episode, Parth Khanna, CEO of ACTO, speaks with Tim Cole, Founder and CEO of The Compass Alliance and the Author of The…
John Constantine, Senior VP at Orchestrall, Inc: How to accelerate drug and device launch in the post-COVID world
The Launchpad Podcast highlights change agents working to disrupt life sciences and their strategies for success in the ever-changing post-market promotion landscape.
In our second episode, Parth Khanna, CEO of ACTO, speaks with John Constantine, Senior VP of Talent Solutions at Orchestrall, Inc. a…
Bill Seitz, VP of Sales and Marketing at Monaghan Medical: Tailoring Your Clinical and Brand Story with Integrity
The Launchpad Podcast highlights change agents working to disrupt life sciences and their strategies for success in the ever-changing post-market promotion landscape.
In our first ever episode, Parth Khanna, CEO of ACTO, speaks with Bill Seitz, VP of Sales and Marketing at Monaghan Medical about bu…
050 – Part 3 – The Future of Mobile Learning and Training
Loyal Learn to Win Fans –
We are thrilled to announce that this is our final episode of Learn to Win and want to share a warm THANK YOU joining us on this learning journey!
We took this last episode to reflect on a few of our favorite insights, and share some clips of the Future of Mobile L…
The Omnichannel Learning Journey with Parth Khanna
Featuring: Parth Khanna, CEO & Co-Founder of ACTO.Parth is a leader and expert in the life sciences industry, as well as the CEO and co-founder of ACTO. He holds an undergraduate degree in neuropsychology, two law degrees, and numerous patents in artificial intelligence. He has received countless n…
Team Human: AI, Innovation and the Future of Medicine
In this episode, Acto co-founder and CEO Parth Khanna joins Michael VanZetta to discuss how artificial intelligence is transforming the life sciences industry and reshaping the future of work. From accelerating drug discovery to supporting pharmaceutical professionals in bringing therapies to patie…
Ep11 - The Hidden Role of L&D in Shaping AI-Driven Future of Work with Parth Khanna
AI is reshaping the future of work, but success depends on more than technology. In this episode of Inside Pharma Leadership, I sit down with Parth Khanna, CEO and Co-Founder of ACTO, to explore how AI, agents, and augmented intelligence are transforming learning & development, frontline leadership…
Ep12 - The Future of Pharma Learning: AI Agents, Trust & Human Judgment (Part 2) with Parth Khanna
What does it take to successfully scale AI across life sciences—and why are so many AI initiatives falling short?
In Part 2 of this conversation, I am joined once again by Parth Khanna, CEO and Co-Founder of ACTO, to explore how AI agents are transforming Learning & Development, commercial teams, …
How Empathetic AI is Creating Bionic Employees in Life Sciences? | Parth Khanna
Empathetic AI and the Future of Work in Life Sciences #aiinlifesciences #pharmaai #biotechbytes
Artificial intelligence is shifting how biotech and pharmaceutical teams operate in the field. Rather than replacing sales reps or medical science liaisons, the real power of technology comes from making…
Pharmaceutical Executive Daily: Eli Lilly Enters $2.8 Billion Agreement to Acquire Merida Biosciences
Eli Lilly agrees to acquire Merida Biosciences for up to $2.875 billion, BioNTech halts a Phase II trial of its cancer immunotherapy Cevumeran, and Parth Khanna argues that more competitive data doesn't mean better intelligence in pharma.
WYSZUKIWARKA PODCASTÓW
Możesz skorzystać z naszej strony internetowej, aby wyszukiwać podcasty3,822,672i odcinki195,596,809według osób, miejsc lub tematów.
Inwestycja w wiedzę przynosi największe zyski, dlatego słucham podcastów.
‐ Benjamin "Llamacorn" Franklin
EDYTUJ
Dziękujemy za pomoc w aktualizowaniu podcastowej bazy danych.
